You are a representative for Mylan, a pharmaceutical company. You will be making a presentation to a select group of American shareholders in person, which will also be recorded and later broadcast on television in the United States.

You are a representative for Mylan, a pharmaceutical company. You will be making a presentation to a select group of American shareholders in person, which will also be recorded and later broadcast on television in the United States. Your presentation should account for all relevant evidence and should emphasize strengths and acknowledge but minimize weaknesses. You have 3-5 minutes to inform shareholders, in detail, of:
1. Mylans actions since July 2016 when major news outlets began covering public outrage over recent significant price increases for the product Epi-Pen; and
2. Mylans plans to put the company back on track.
You will need to argue to existing shareholders how Mylan is responding and why shareholders should keep their investment in the company. You may also want to address potential shareholders as to why this is a good time to further invest in the company. You should research the origin of the crisis, but your presentation should be based on Mylans current situation (present-day). Your conclusions must be supported by specific, identifiable facts.